- Medication Helps Decrease Opioid Use
Medication Helps Decrease Opioid Use
Bottom Line: Patients who received the nonopioid pain medication gabapentin before and after surgery were somewhat more likely to stop using opioids after surgery.
Why The Research Is Interesting: Millions of Americans undergo surgery each year and most are prescribed opioids for pain management. Some of these patients become chronic users of opioids.
Who and When: Patients scheduled for surgery from May 2010 to July 2014 and followed up to two years
What (Study Measures): Gabapentin before and after surgery or the active placebo lorazepam before surgery and an inactive placebo after surgery (interventions); time to pain resolution (five consecutive reports of zero on a pain scale) and time to opioid cessation (five consecutive reports of no opioid use) (outcomes); 410 patients were separated nearly evenly into gabapentin or placebo treatment groups
How (Study Design): This was a randomized clinical trial (RCT). An RCT allows for the strongest inferences to be made about the true effect of an intervention. However, not all RCT results can be replicated in real-world settings because patient characteristics or other variables may differ from those that were studied in the RCT.
Authors: Jennifer Hah, M.D., M.S., Stanford University, Palo Alto, California, and coauthors.
Gabapentin before and after surgery had no effect compared with placebo on time to cessation of pain.
Patients who received gabapentin had a modest increase in opioid cessation.
Study Limitations: Physicians could prescribe different medications to different patients and this could have affected outcomes.
Study Conclusions: Routine use of gabapentin before and after surgery may be warranted if it can promote opioid cessation and prevent chronic use of opioids.
The following related elements also are available on the For The Media website:
The commentary, “The Role of Gabapentin in Multimodal Postoperative Pain Management, by Michael A. Ashburn, M.D., M.P.H., and Lee A. Fleisher, M.D., of the University of Pennsylvania, Philadelphia .
For more details and to read the full study, please visit the For The Media website.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2018, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.